The outcomes of S100A9 overexpression on hyperglycemia and polydipsia were minor as these parameters were only slightly improved in DT-pLIVE-S100A9 compared to DT-pLIVE mice (Fig. 3g and Supplementary Fig. 3d). Here, S100A9 is linked to Polydipsia.